Tomorrow's Science For Today's Clinician
Collective results from recent clinical trials indicate that an oral drug called roxadustat is an effective treatment for anemia in patients with chronic kidney disease who do not require dialysis. The results were published in an upcoming issue of CJASN.
A study led by researchers from University of Birmingham showed that an oral drug, fenofibrate and its active form fenofibric acid used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent.
The Indian Council of Medical Research said on Sunday that a combination of Covishield and Covaxin gives better protection to the human body than two doses of the same vaccine.
India reported 36,036 new COVID-19 incidences on Sunday. With as many as 447 fatalities were recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,27,401.
WHO and HRP have launched a new guidelines to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer — a disease which is both preventable and treatable.
The mandatory internship for MBBS students proposed by National Medical Commission (NMC) in AYUSH streams has drawn sharp reactions from allopathic practitioners and students of modern medicine.
The conduct of clinical trials in paediatric populations poses unique challenges because of the differences in physiology and cognition between children and adults.
In an interaction with Divya Choyikutty, she speaks about the latest medical technologies in gynaec-oncology and the new programmes she is involved with for creating qualified gynaecologists, and shares her experience in the field.
India reported 38,705 new COVID-19 incidences on Friday. With as many as 616 fatalities were recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,27,401.
Aresearch team led by physicians of the Karl Landsteiner University of Health Sciences in Krems has identified a potential drug target to treat multiple myeloma (MM) by uncovering a pivotal role for a regulator protein.